Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jingwei Zheng, Jingsong Huang, Wei Ma, Wenqiang Yang & Bicheng Hu. (2021) The Antitumor Activity of CAR-T-PD1 Cells Enhanced by HPV16mE7-Pulsed and SOCS1-Silenced DCs in Cervical Cancer Models. Cancer Management and Research 13, pages 6045-6053.
Read now
Read now
Fernando Aranda, Aitziber Buqué, Norma Bloy, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Adoptive cell transfer for oncological indications. OncoImmunology 4:11.
Read now
Read now
Aitziber Buqué, Norma Bloy, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Aurélien Marabelle, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. OncoImmunology 4:4.
Read now
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:3.
Read now
Read now
Articles from other publishers (14)
Nicholas Cunningham, Réjean Lapointe & Sophie Lerouge. (2022) Biomaterials for enhanced immunotherapy. APL Bioengineering 6:4.
Crossref
Crossref
Vesna Risso, Elodie Lafont & Matthieu Le Gallo. (2022) Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases. Cell Death & Disease 13:3.
Crossref
Crossref
Javier Glez-Vaz, Arantza Azpilikueta, Irene Olivera, Assunta Cirella, Alvaro Teijeira, Maria C Ochoa, Maite Alvarez, Iñaki Eguren-Santamaria, Carlos Luri-Rey, Maria E Rodriguez-Ruiz, Xinxin Nie, Lieping Chen, Sonia Guedan, Miguel F Sanmamed, Jose Luis Perez Gracia & Ignacio Melero. (2022) Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. Journal for ImmunoTherapy of Cancer 10:3, pages e003532.
Crossref
Crossref
Yu Zhao, Yu-Qing Xie, Simon Van HerckSina NassiriMin Gao, Yugang Guo & Li Tang. (2021) Switchable immune modulator for tumor-specific activation of anticancer immunity. Science Advances 7:37.
Crossref
Crossref
John E. Mullinax, MacLean Hall, Matthew Beatty, Amy M. Weber, Zachary Sannasardo, Tanja Svrdlin, Jonathan Hensel, Marilyn Bui, Allison Richards, Ricardo J. Gonzalez, Cheryl A. Cox, Linda Kelley, James J. Mulé, Amod A. Sarnaik & Shari Pilon-Thomas. (2021) Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific Function. Journal of Immunotherapy 44:2, pages 63-70.
Crossref
Crossref
Stina Wickström & Tanja Lövgren. 2019. Immune Checkpoint Blockade. Immune Checkpoint Blockade
105
118
.
Jonathan E Cohen, Sharon Merims, Stephen Frank, Roni Engelstein, Tamar Peretz & Michal Lotem. (2017) Adoptive cell therapy: past, present and future. Immunotherapy 9:2, pages 183-196.
Crossref
Crossref
Drew C Deniger, Anna Pasetto, Eric Tran, Maria R Parkhurst, Cyrille J Cohen, Paul F Robbins, Laurence JN Cooper & Steven A Rosenberg. (2016) Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System. Molecular Therapy 24:6, pages 1078-1089.
Crossref
Crossref
Krithika N. Kodumudi, Jessica Siegel, Amy M. Weber, Ellen Scott, Amod A. Sarnaik & Shari Pilon-Thomas. (2016) Immune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy. PLOS ONE 11:4, pages e0153053.
Crossref
Crossref
M.H. Geukes Foppen, M. Donia, I.M. Svane & J.B.A.G. Haanen. (2015) Tumor‐infiltrating lymphocytes for the treatment of metastatic cancer. Molecular Oncology 9:10, pages 1918-1935.
Crossref
Crossref
Michal J. Besser, Ronnie Shapira-Frommer & Jacob Schachter. (2015) Tumor-Infiltrating Lymphocytes. The Cancer Journal 21:6, pages 465-469.
Crossref
Crossref
Jessica Chacon, Krit Ritthipichai, Geok Sim, Michiko Harao, Jie Qing Chen, Caitlin Creasy, Chantale Bernatchez, Patrick Hwu & Laszlo Radvanyi. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
151
181
.
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref
Karsten A Pilones, Joseph Aryankalayil, James S Babb & Sandra Demaria. (2014) Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes. Journal for ImmunoTherapy of Cancer 2:1.
Crossref
Crossref